AAPL329.74-3.28 (-0.98%) ▼|ABBV260.24-1.35 (-0.52%) ▼|ABT97.47-1.37 (-1.38%) ▼|ACN216.39+33.02 (+18.00%) ▲|ADBE241.59+1.65 (+0.69%) ▲|AMAT529.73+18.35 (+3.59%) ▲|AMD616.71+4.95 (+0.81%) ▲|AMGN410.16-11.35 (-2.69%) ▼|AMT161.43-2.27 (-1.38%) ▼|AMZN249.21+0.06 (+0.02%) ▲|AVGO348.91-2.29 (-0.65%) ▼|AXP300.50-3.60 (-1.18%) ▼|BA189.54+3.49 (+1.87%) ▲|BAC53.73-0.71 (-1.30%) ▼|BKNG161.10-1.81 (-1.11%) ▼|BLK1,070.35+12.06 (+1.14%) ▲|BMY61.52-0.88 (-1.41%) ▼|BNY143.51-1.12 (-0.77%) ▼|BRK-B498.93+0.98 (+0.20%) ▲|C127.22-2.26 (-1.75%) ▼|CAT826.28+15.49 (+1.91%) ▲|CL84.53-0.80 (-0.93%) ▼|CMCSA21.75-0.02 (-0.07%) ▼|COF193.10+0.03 (+0.02%) ▲|COP126.61+1.46 (+1.17%) ▲|COST916.99+6.65 (+0.73%) ▲|CRM234.66+5.09 (+2.22%) ▲|CSCO108.45+0.82 (+0.76%) ▲|CVS85.52-0.17 (-0.20%) ▼|CVX206.49+2.28 (+1.12%) ▲|DE662.60-8.95 (-1.33%) ▼|DHR213.26-8.29 (-3.74%) ▼|DIS101.55-3.35 (-3.19%) ▼|DUK113.64-0.38 (-0.33%) ▼|EMR157.67+2.57 (+1.66%) ▲|FDX286.99+1.90 (+0.66%) ▲|GD333.06+1.23 (+0.37%) ▲|GE312.56+0.27 (+0.08%) ▲|GEV990.35+39.86 (+4.19%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM78.10+1.10 (+1.43%) ▲|GOOG336.08-4.67 (-1.37%) ▼|GOOGL339.32-4.76 (-1.38%) ▼|GS896.34-4.02 (-0.45%) ▼|HD281.58-2.91 (-1.02%) ▼|HON213.64+2.70 (+1.28%) ▲|IBM227.97+8.04 (+3.66%) ▲|INTC121.35+1.12 (+0.93%) ▲|INTU283.23+7.52 (+2.73%) ▲|ISRG401.47-5.17 (-1.27%) ▼|JNJ258.61-6.14 (-2.32%) ▼|JPM332.51+1.68 (+0.51%) ▲|KO85.80-0.29 (-0.33%) ▼|LIN468.57-6.08 (-1.28%) ▼|LLY1,140.46-16.63 (-1.44%) ▼|LMT506.45-2.80 (-0.55%) ▼|LOW182.12-2.18 (-1.18%) ▼|LRCX337.28+8.77 (+2.67%) ▲|MA549.46-2.01 (-0.36%) ▼|MCD231.33+0.39 (+0.17%) ▲|MDLZ57.71-0.11 (-0.19%) ▼|MDT85.58-0.72 (-0.83%) ▼|META728.48+3.30 (+0.45%) ▲|MMM162.69-1.47 (-0.89%) ▼|MO66.84-0.51 (-0.75%) ▼|MRK143.53-1.78 (-1.23%) ▼|MS187.18-0.91 (-0.48%) ▼|MSFT515.47+2.57 (+0.50%) ▲|MU1,091.50+26.39 (+2.48%) ▲|NEE76.30+0.56 (+0.73%) ▲|NFLX68.33-1.25 (-1.80%) ▼|NKE35.93+0.53 (+1.50%) ▲|NOW137.73+3.72 (+2.77%) ▲|NVDA230.76+2.38 (+1.04%) ▲|ORCL138.81+1.51 (+1.10%) ▲|PEP125.81-0.91 (-0.72%) ▼|PFE28.18-0.34 (-1.20%) ▼|PG144.15-1.13 (-0.78%) ▼|PLTR189.53+2.48 (+1.32%) ▲|PM187.40-3.43 (-1.79%) ▼|QCOM185.01+0.97 (+0.53%) ▲|RTX184.90-0.75 (-0.40%) ▼|SBUX94.35+0.39 (+0.42%) ▲|SCHW98.05+0.31 (+0.31%) ▲|SO83.20+0.31 (+0.37%) ▲|SPG200.15-0.62 (-0.31%) ▼|T24.38-0.03 (-0.10%) ▼|TMO657.40-17.65 (-2.61%) ▼|TMUS161.98-1.10 (-0.67%) ▼|TSLA355.81+1.00 (+0.28%) ▲|TXN281.30+1.21 (+0.43%) ▲|UBER67.98-0.54 (-0.78%) ▼|UNH364.69-2.39 (-0.65%) ▼|UNP270.44-1.69 (-0.62%) ▼|UPS93.99+0.55 (+0.58%) ▲|USB56.77-1.00 (-1.72%) ▼|V358.96-0.37 (-0.10%) ▼|VZ46.01+0.14 (+0.29%) ▲|WFC79.51-0.54 (-0.67%) ▼|WMT104.87+0.95 (+0.91%) ▲|XOM163.83+1.08 (+0.66%) ▲|AAPL329.74-3.28 (-0.98%) ▼|ABBV260.24-1.35 (-0.52%) ▼|ABT97.47-1.37 (-1.38%) ▼|ACN216.39+33.02 (+18.00%) ▲|ADBE241.59+1.65 (+0.69%) ▲|AMAT529.73+18.35 (+3.59%) ▲|AMD616.71+4.95 (+0.81%) ▲|AMGN410.16-11.35 (-2.69%) ▼|AMT161.43-2.27 (-1.38%) ▼|AMZN249.21+0.06 (+0.02%) ▲|AVGO348.91-2.29 (-0.65%) ▼|AXP300.50-3.60 (-1.18%) ▼|BA189.54+3.49 (+1.87%) ▲|BAC53.73-0.71 (-1.30%) ▼|BKNG161.10-1.81 (-1.11%) ▼|BLK1,070.35+12.06 (+1.14%) ▲|BMY61.52-0.88 (-1.41%) ▼|BNY143.51-1.12 (-0.77%) ▼|BRK-B498.93+0.98 (+0.20%) ▲|C127.22-2.26 (-1.75%) ▼|CAT826.28+15.49 (+1.91%) ▲|CL84.53-0.80 (-0.93%) ▼|CMCSA21.75-0.02 (-0.07%) ▼|COF193.10+0.03 (+0.02%) ▲|COP126.61+1.46 (+1.17%) ▲|COST916.99+6.65 (+0.73%) ▲|CRM234.66+5.09 (+2.22%) ▲|CSCO108.45+0.82 (+0.76%) ▲|CVS85.52-0.17 (-0.20%) ▼|CVX206.49+2.28 (+1.12%) ▲|DE662.60-8.95 (-1.33%) ▼|DHR213.26-8.29 (-3.74%) ▼|DIS101.55-3.35 (-3.19%) ▼|DUK113.64-0.38 (-0.33%) ▼|EMR157.67+2.57 (+1.66%) ▲|FDX286.99+1.90 (+0.66%) ▲|GD333.06+1.23 (+0.37%) ▲|GE312.56+0.27 (+0.08%) ▲|GEV990.35+39.86 (+4.19%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM78.10+1.10 (+1.43%) ▲|GOOG336.08-4.67 (-1.37%) ▼|GOOGL339.32-4.76 (-1.38%) ▼|GS896.34-4.02 (-0.45%) ▼|HD281.58-2.91 (-1.02%) ▼|HON213.64+2.70 (+1.28%) ▲|IBM227.97+8.04 (+3.66%) ▲|INTC121.35+1.12 (+0.93%) ▲|INTU283.23+7.52 (+2.73%) ▲|ISRG401.47-5.17 (-1.27%) ▼|JNJ258.61-6.14 (-2.32%) ▼|JPM332.51+1.68 (+0.51%) ▲|KO85.80-0.29 (-0.33%) ▼|LIN468.57-6.08 (-1.28%) ▼|LLY1,140.46-16.63 (-1.44%) ▼|LMT506.45-2.80 (-0.55%) ▼|LOW182.12-2.18 (-1.18%) ▼|LRCX337.28+8.77 (+2.67%) ▲|MA549.46-2.01 (-0.36%) ▼|MCD231.33+0.39 (+0.17%) ▲|MDLZ57.71-0.11 (-0.19%) ▼|MDT85.58-0.72 (-0.83%) ▼|META728.48+3.30 (+0.45%) ▲|MMM162.69-1.47 (-0.89%) ▼|MO66.84-0.51 (-0.75%) ▼|MRK143.53-1.78 (-1.23%) ▼|MS187.18-0.91 (-0.48%) ▼|MSFT515.47+2.57 (+0.50%) ▲|MU1,091.50+26.39 (+2.48%) ▲|NEE76.30+0.56 (+0.73%) ▲|NFLX68.33-1.25 (-1.80%) ▼|NKE35.93+0.53 (+1.50%) ▲|NOW137.73+3.72 (+2.77%) ▲|NVDA230.76+2.38 (+1.04%) ▲|ORCL138.81+1.51 (+1.10%) ▲|PEP125.81-0.91 (-0.72%) ▼|PFE28.18-0.34 (-1.20%) ▼|PG144.15-1.13 (-0.78%) ▼|PLTR189.53+2.48 (+1.32%) ▲|PM187.40-3.43 (-1.79%) ▼|QCOM185.01+0.97 (+0.53%) ▲|RTX184.90-0.75 (-0.40%) ▼|SBUX94.35+0.39 (+0.42%) ▲|SCHW98.05+0.31 (+0.31%) ▲|SO83.20+0.31 (+0.37%) ▲|SPG200.15-0.62 (-0.31%) ▼|T24.38-0.03 (-0.10%) ▼|TMO657.40-17.65 (-2.61%) ▼|TMUS161.98-1.10 (-0.67%) ▼|TSLA355.81+1.00 (+0.28%) ▲|TXN281.30+1.21 (+0.43%) ▲|UBER67.98-0.54 (-0.78%) ▼|UNH364.69-2.39 (-0.65%) ▼|UNP270.44-1.69 (-0.62%) ▼|UPS93.99+0.55 (+0.58%) ▲|USB56.77-1.00 (-1.72%) ▼|V358.96-0.37 (-0.10%) ▼|VZ46.01+0.14 (+0.29%) ▲|WFC79.51-0.54 (-0.67%) ▼|WMT104.87+0.95 (+0.91%) ▲|XOM163.83+1.08 (+0.66%) ▲|
25.6 C
New York
Thursday, October 1, 2026

Tag: FOR

newssourceFORcompanyinformationcontent1releasesmarket

SKG Launches PS700 Neck Massager, Bringing Deep Kneading, Layered Heat, and Immersive Audio to Everyday Recovery

The new wearable recovery device pairs deep-kneading massage, layered warmth, and immersive audio to help ease neck tension 
The new wearable recovery device pairs deep-kneading massage, layered warmth, and immersive audio to help ease neck tension

All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration

NEW YORK, June 06, 2026 (GLOBE NEWSWIRE) -- All In FutureTech Alliance (Nasdaq: AIFA) (“AIFA” or the “Company”) today provided a strategic update. Following the Company’s previously announced signing of agreements to acquire a controlling interest in HyalRoute Communication Group (“HyalRoute”) and advancement of the Hainan AIFA Silicon Photonics Supercomputing Center project, the Company is further accelerating project planning, policy coordination, financing arrangements, and cross-border resource integration around its dual-engine strategy of an “AI infrastructure network powered by optical technologies” and an “AI application services matrix.”

Horse Boost For Men Claims Evaluated: Documenting Horse Boost Male Enhancement: A New Male Wellness Supplement Amid Growing Interest in Men’s Health Solutions

Horse Boost for Men supports male vitality, energy, stamina, endurance, and active lifestyles with targeted nutritional support. 
Horse Boost for Men supports male vitality, energy, stamina, endurance, and active lifestyles with targeted nutritional support.

People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more...

Adults with type 2 diabetes on semaglutide 1 mg whose dose was increased to 2 mg were as likely to reach an HbA1c level...

Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes

New research supports monthly dosing as a next‑generation opportunity to improve weight lossNEW ORLEANS, June 6, 2026 /PRNewswire/ -- New data highlight the potential...

Former Pentagon Advisor: “The $2 Stock Sitting on America’s Greatest Untapped Treasure”

The opportunity has a June 30 deadline. One small company holds the key. And most Americans have no idea. 
The opportunity has a June 30 deadline. One small company holds the key. And most Americans have no idea.

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect earlyKetone monitoring is not yet routine in diabetes care, which may...

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sportradar Group AG Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRAD

NEW YORK, June 06, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A ordinary shares of Sportradar Group AG (NASDAQ: SRAD) between November 7, 2024 and April 21, 2026, inclusive (the “Class Period”), of the important July 17, 2026 lead plaintiff deadline.

RGC DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important June 23 Deadline in Securities...

NEW YORK, June 06, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”), of the important June 23, 2026 lead plaintiff deadline.

Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded

Chandigarh University Sings MoU with Global Consulting Giant PwC to Offer Online MBA Program330 Postgraduate and 33 Undergraduate Degrees Conferred to Online and Distance...

Fox ESS Unveils Dynamic Energy Ecosystem Alongside Its First Rebrand Area at SNEC 2026

SHANGHAI, June 6, 2026 /PRNewswire/ -- Fox ESS, a global leader in renewable energy solutions, successfully concluded SNEC 2026 following the official launch of its...

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast, Bharuch district, GujaratEmployees and communities work together to conserve...

Leading Vision Insurance for Glasses (2026): VSP Individual Vision Plans Named Top Plan for Frames and Lens Coverage by Better Business Advice

NEW YORK, June 6, 2026 /PRNewswire/ -- VSP® Individual Vision Plans has been recognized by Better Business Advice as a top vision insurance option...

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978 

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFOR

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers